Cosmetic Injectables: Emerging Uses, Techniques, and Data
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Overview
This certified CME activity is designed for dermatologists and dermatology residents.Jointly sponsored by The Dulaney Foundation and Practical Dermatology® Supported by an unrestricted educational grant from Allergan, Inc. This continuing medical educational activity is supported by an unrestricted educational grant from Allergan, Inc. Learning Objectives
Upon completion of this activity, the participant should be able to: - Identify various uses of injectable fillers, their associated treatment regimens, and manage adverse events
- Know the current developments in the field of cosmetic surgery and implement them in practice
- Apply strategies to improve management of complications and proper patient selection to avoid dissatisfaction
- Effectively educate patients about known risks associated with cosmetic therapies
- Establish protocols in their practices to monitor and disseminate accurate information about emerging therapeutic concerns
- Formulate and implement advanced patient satisfaction evaluation methods
- Utilize cosmetic treatment procedures that result in patient satisfaction, low risk-benefit ratio, and improved quality of life for patients
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Dulaney Foundation and Practical Dermatology. The Dulaney Foundation is accredited by the ACCME to provide continuing education for physicians. The Dulaney Foundation designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participation Method
After reviewing the material, please complete the self-assessment test, which consists of a series of multiple-choice questions. To answer these questions online and receive real-time results, please visit http://www.dulaneyfoundation.org and click “Online Courses.” Upon completing the activity and achieving a passing score of over 70 percent on the self-assessment test, you may print out a CME credit letter awarding 1 AMA PRA Category 1 Credit.™ The estimated time to complete this activity is 1 hour. Faculty and Disclosures
DISCLOSURE POLICY
<u>Faculty Credentials</u> Macrene Alexiades-Armenakas, MD, PhD, FAAD is Assistant Clinical Professor at Yale University School of Medicine, New Haven, CT. She is founder and Director at NY Derm LLC in New York, NY. David E. Bank, MD, FAAD is Director, The Center for Dermatology, Cosmetic & Laser Surgery in Mt. Kisko, NY. Vic A. Narurkar MD, FAAD is the cofounder of Cosmetic Boot Camp LLC and founder of the Bay Area Laser Institute in San Francisco. He serves on the board of directors of the ASDS and is the chair of dermatology at California Pacific Medical Center, San Francisco, CA. Susan H. Weinkle, MD, FAAD is board-certified in dermatology. She is a Fellow of the American College of Mohs Surgery and Cutaneous Oncology and a Diplomat of the American Board of Dermatology. She is in private practice in Bradenton, FL.<p> <u>Faculty/Staff Disclosure Declarations</u> Dr. Alexiades-Armenakas has disclosed no relevant conflicts of interest. Dr. Bank has disclosed the following relevant financial relationships: Allergan, Inc. and Medicis Pharmaceutical Corporation. Dr. Narurkar has disclosed the following relevant financial relationships: Allergan, Inc.; Merz, Pharmaceuticals, LLC; Myoscience; Palomar Medical Technologies, Inc.; Philips Healthcare and ZELTIQ Aesthetics, Inc. Dr. Weinkle has disclosed the following relevant financial relationships: Allergan, Inc.; DermAdvance; Ethicon, Inc.; Galderma Laboratories, LP;Kythera; Medicis Pharmaceutical Corporation; Myoscience; Procter & Gamble Pharmaceuticals; TEOXANE Laboratories; and Valeant Pharmaceuticals International. All of those involved in the planning, editing, and peer review of this educational activity report no relevant financial relationships.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
In accordance with the disclosure policies of The Dulaney Foundation and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices or providers of commercial services and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!